OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
PTSM: Pharmaceutical Technology Sourcing and Management
Stability testing and UPLC capabilities highlight expansion at Mumbai, India facility of SGS Life Science Services.
SGS Life Science Services, a clinical and bioanalytical contract solutions provider, has announced the completion of an expansion at its Mumbai, India, facility with validation of new equipment currently underway; an official opening of the laboratory is planned for May 20, 2015.
The expansion has seen the previous 1,393-square meter laboratory space more than double in size, to 3,400 square meters; once validation is completed, the laboratory will act as a dedicated cGMP pharmaceutical testing site. The workforce has increased from 65 to 115, with the potential for up to another 40 employees in the additional facilities, according to a company statement.
Investment at the laboratory focused on increasing stability chamber capacity, and in supporting chromatography equipment, including new UPLC capabilities. The Mumbai facility now has the largest stability testing facility in the SGS Life Science Services’ global network, with the expansion driven by the increased demand from both local and international customers, the company reports.
Three new 100-cubic meter capacity stability chambers have been installed for 21 CFR part 11-compliant short term, long term, and accelerated studies, and covers all the International Conference of Harmonisation (ICH) conditions, as well as flexibility for specific client conditions. The Mumbai expansion follows SGS’s renovation of its Chennai, India, laboratory in 2014, increasing laboratory space within the facility. The number of employees increased from 60 to 75, with the flexibility to further accommodate up to 90.
Source: SGS Life Science Services